These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7786397

  • 1. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents.
    Magarian RA, Avor KS, Overacre LB, Kunchandy J, Paxton TR.
    Anticancer Drug Des; 1995 Jun; 10(4):311-31. PubMed ID: 7786397
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of a series of gem-dichlorocyclopropanes as antitumor agents.
    Griffin MT, Magarian RA, Jain P, Pento JT, Mousissian GK, Graves DC.
    Anticancer Drug Des; 1992 Feb; 7(1):49-66. PubMed ID: 1543527
    [Abstract] [Full Text] [Related]

  • 3. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS, Parker CJ, McCague R, Jordan VC.
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [Abstract] [Full Text] [Related]

  • 4. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer.
    Leclercq G, Devleeschouwer N, Heuson JC.
    J Steroid Biochem; 1983 Jul; 19(1A):75-85. PubMed ID: 6887875
    [Abstract] [Full Text] [Related]

  • 5. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Res; 1992 Jul; 12(3):585-90. PubMed ID: 1622114
    [Abstract] [Full Text] [Related]

  • 6. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 7. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
    ter Haar E, Hamel E, Balachandran R, Day BW.
    Anticancer Res; 1997 Nov; 17(3C):1861-9. PubMed ID: 9216636
    [Abstract] [Full Text] [Related]

  • 8. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E, Day BW.
    Anticancer Res; 1996 Nov; 16(3A):1107-15. PubMed ID: 8702221
    [Abstract] [Full Text] [Related]

  • 9. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E, Borgna JL, Rochefort H.
    Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
    [Abstract] [Full Text] [Related]

  • 11. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL.
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [Abstract] [Full Text] [Related]

  • 12. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N, Barberi-Heyob M, Merlin JL, Ledrich ML, Batt AM, Guillemin F.
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
    Pihie AH, Stanslas J, Din LB.
    Anticancer Res; 1998 Oct; 18(3A):1739-43. PubMed ID: 9673398
    [Abstract] [Full Text] [Related]

  • 15. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C, Pons JF, Duchesne MJ, Auzou G, Pons M, Nique F, Teutsch G, Borgna JL.
    J Med Chem; 1997 Jul 04; 40(14):2217-27. PubMed ID: 9216841
    [Abstract] [Full Text] [Related]

  • 16. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
    Kawamura I, Lacey E, Mizota T, Tsujimoto S, Nishigaki F, Manda T, Shimomura K.
    Anticancer Res; 1994 Jul 04; 14(2A):427-31. PubMed ID: 8017842
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
    Nguyen A, Top S, Pigeon P, Vessières A, Hillard EA, Plamont MA, Huché M, Rigamonti C, Jaouen G.
    Chemistry; 2009 Jul 04; 15(3):684-96. PubMed ID: 19053086
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro.
    Jordan VC, Lieberman ME, Cormier E, Koch R, Bagley JR, Ruenitz PC.
    Mol Pharmacol; 1984 Sep 04; 26(2):272-8. PubMed ID: 6482874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.